XML 58 R42.htm IDEA: XBRL DOCUMENT
v3.25.4

Basic Loss Per Share (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Basic Loss Per Share [Abstract] |
Schedule of Basic and Diluted Net Loss Per Share | The basic and diluted net loss per share and weighted average number of shares of Common Stock used in the calculation of basic and diluted net loss per share are as follows:
|  | For the year ended December 31, |
|  | 2025 |  |  | 2024 |
Basic and diluted loss per share of common stock |  |  |  |  |  |
Numerator: |  |  |  |  |  |
Net loss |  |  | 36,199 |  |  |  | 17,727 |
Denominator: |  |  |  |  |  |  |  |
Number of shares of common stock outstanding |  |  | 1,422,019 |  |  |  | 698,853 |
Number of shares upon Pre-Funded Warrants exercise |  |  | 209,001 |  |  |  | - |
Number of shares upon fully vested Warrants exercise |  |  | 17 |  |  |  | 17 |
Total weighted-average number of shares of common stock, shares upon Pre-Funded Warrants and fully vested Warrants exercise used in computing basic loss per share |  |  | 1,631,037 |  |  |  | 698,870 |
Basic loss per share of common stock |  |  | 22.19 |  |  |  | 25.37 |
Diluted net loss per share of common stock |  |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |  |
Net loss |  |  | 36,199 |  |  |  | 17,727 |
Change in fair value of Private Placement Warrants |  |  | - |  |  |  | 26,458 |
Diluted net loss |  |  | 36,199 |  |  |  | 44,185 |
Denominator: |  |  |  |  |  |  |  |
Weighted-average number of shares of common stock outstanding |  |  | 1,631,037 |  |  |  | 698,870 |
Private Placement Warrants |  |  | - |  |  |  | 58,879 |
Total weighted-average number of shares of common stock outstanding, after giving effect to dilutive securities |  |  | 1,631,037 |  |  |  | 757,749 |
Diluted net loss per share of common stock |  |  | 22.19 |  |  |  | 58.31 |
Schedule of Anti-Dilutive Financial Instruments | The calculation of diluted loss per share as of December 31, 2025 and 2024, does not include the shares underlying the following financial instruments because their effect would be anti-dilutive:
|  | For the year ended December 31, |
|  | 2025 |  |  | 2024 |
Options |  |  | 150,387 |  |  |  | 105,388 |
Warrants |  |  | 959,687 |  |  |  | 77,647 |
Contingent shares |  |  | 10,526 |  |  |  | 10,526 |
Redeemable Convertible Preferred Shares |  |  | 776,383 |  |  |  | 777,553 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration